Baylor, Scott & White Medical Center - Temple

Temple, Texas 76508-0001

6 studies enrolling now · 25 studies all time

What they study most

Abiraterone Acetate, Acute Decompensated Heart Failure, Acute Heart Failure, Acute Respiratory Failure, Androgens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Aortic Stenosis, Arthritis, Rheumatoid, Breast Neoplasms, COVID-19, Cancer

Studies at this site

• MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL — Recruiting now
• Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries — Recruiting now
• The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers. — Recruiting now
• Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center — Recruiting now
• A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer — Running, not enrolling
• A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described — Running, not enrolling
• Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin — Running, not enrolling
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — Running, not enrolling
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• Continuous Glucose Monitoring of Hospitalized Patients With Diabetes — Completed
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) — Completed
• Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement — Completed
• Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — Completed
• SVC Occlusion in Subjects With Acute Decompensated Heart Failure — Completed
• A Study of IMR-687 in Subjects With Sickle Cell Disease — Stopped early
• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed
• Treatments Against RA and Effect on FDG-PET/CT — Completed
• An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia — Running, not enrolling
• Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma — Stopped early
• Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine — Completed
• Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation — Completed